// App-Quantinova.ai

: Edoxaban For Pediatric Patients With Cardiac Diseases A Randomized, Open Label, Multicenter Study

Researchers

Presenter

  • Michael A Portman

Principal Investigators

  • Jeffrey P Jacobs

  • Jane W Newburger

  • Felix Berger

  • Michael A Grosso

  • Anil C Duggal

  • Neil A Goldenberg

Medical Centers

  • Seattle Children's, Seattle, WA

  • CHILDRENS HOSPITAL BOSTON, Boston, MA

  • University of South Florida, St. Petersburg, FL

  • Daiichi Sankyo, Inc., Edison, NJ

  • Deutsches Herzzentrum Berlin, Berlin, Germany

  • John's Hopkins All Children's Heart Inst, Saint Petersburg, FL

  • DAIICHI SANKYO, Basking Ridge, NJ

Locations

  • Germany

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Kawasaki disease

  • Congestive heart failure

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Edoxaban

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Open Label

  • Multinational

  • Multicenteric

  • Prospective

Phase

  • III

Study Id's

  • NCT00687882

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved